Pureos Bioventures
Pureos Bioventures invests in private biotech firms developing next-gen biologics, focusing on oncology, immunology, ophthalmology, rare diseases, and neuroscience. Backed by scientific excellence and clinical expertise.
Funding Stage: Series A/B, Series C & Beyond
Investor type: VC Firm
Investment Areas: Diagnostics, Biopharma, Biotech, Life Sciences
Country: Switzerland
ACCESS DIRECTORY
Details about how we process your information are available in our Privacy Policy.